Related Experiment Video
Updated: Mar 11, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2
Paula Giménez-Mascarell1, Iker Oyenarte1, Serge Hardy2
1From the Structural Biology Unit, Center for Cooperative Research in Biosciences (CIC bioGUNE), Technology Park of Bizkaia, 48160 Derio, Bizkaia, Spain.
Abstract:
Phosphatases of regenerating liver (PRLs), the most oncogenic of all protein-tyrosine phosphatases (PTPs), play a critical role in metastatic progression of cancers. Recent findings established a new paradigm by uncovering that their association with magnesium transporters of the cyclin M (CNNM) family causes a rise in intracellular magnesium levels that promote oncogenic transformation. Recently, however, essential roles for regulation of the circadian rhythm and reproduction of the CNNM family have been highlighted. Here, we describe the crystal structure of PRL-1 in complex with the Bateman module of CNNM2 (CNNM2BAT), which consists of two cystathionine β-synthase (CBS) domains (IPR000664) and represents an intracellular regulatory module of the transporter. The structure reveals a heterotetrameric association, consisting of a disc-like homodimer of CNNM2BAT bound to two independent PRL-1 molecules, each one located at opposite tips of the disc. The structure highlights the key role played by Asp-558 at the extended loop of the CBS2 motif of CNNM2 in maintaining the association between the two proteins and proves that the interaction between CNNM2 and PRL-1 occurs via the catalytic domain of the phosphatase. Our data shed new light on the structural basis underlying the interaction between PRL phosphatases and CNNM transporters and provides a hypothesis about the molecular mechanism by which PRL-1, upon binding to CNNM2, might increase the intracellular concentration of Mg2+ thereby contributing to tumor progression and metastasis. The availability of this structure sets the basis for the rational design of compounds modulating PRL-1 and CNNM2 activities.
Insights
The crystal structure reveals how Phosphatases of Regenerating Liver (PRLs) bind to CNNM2 transporters. This interaction increases intracellular magnesium, promoting cancer metastasis and offering targets for new cancer therapies.
Area of Science:
- Biochemistry
- Structural Biology
- Cancer Biology
Background:
- Phosphatases of Regenerating Liver (PRLs) are oncogenic protein-tyrosine phosphatases driving cancer metastasis.
- PRLs associate with Cyclin M (CNNM) transporters, increasing intracellular magnesium and promoting oncogenic transformation.
- CNNM family proteins also regulate circadian rhythms and reproduction.
Purpose of the Study:
- To determine the crystal structure of PRL-1 in complex with the CNNM2 Bateman module (CNNM2BAT).
- To elucidate the structural basis of the PRL-CNNM interaction.
- To provide insights into the mechanism of magnesium transport regulation by PRL-1 and its role in cancer progression.
Main Methods:
- X-ray crystallography to determine the structure of the PRL-1/CNNM2BAT complex.
- Analysis of protein-protein interactions and structural interfaces.
- Hypothesis generation for the molecular mechanism of magnesium transport.
Main Results:
- The crystal structure reveals a heterotetrameric complex: a CNNM2BAT homodimer bound to two PRL-1 molecules.
- The interaction occurs at the catalytic domain of PRL-1 and involves Asp-558 of the CNNM2 CBS2 motif.
- The structure provides a detailed view of the PRL-CNNM2 interface.
Conclusions:
- The study elucidates the structural basis for PRL-CNNM2 interaction.
- This interaction is hypothesized to increase intracellular Mg2+, contributing to tumor progression and metastasis.
- The structure serves as a foundation for designing inhibitors targeting PRL-1 and CNNM2 activities.
More Related Videos
10:17A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
Published on: April 29, 2022
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Abnormal Proliferation